205 related articles for article (PubMed ID: 12699304)
1. New anabolic therapies in osteoporosis.
Rubin MR; Bilezikian JP
Endocrinol Metab Clin North Am; 2003 Mar; 32(1):285-307. PubMed ID: 12699304
[TBL] [Abstract][Full Text] [Related]
2. The anabolic effects of parathyroid hormone therapy.
Rubin MR; Bilezikian JP
Clin Geriatr Med; 2003 May; 19(2):415-32. PubMed ID: 12916294
[TBL] [Abstract][Full Text] [Related]
3. New anabolic therapies in osteoporosis.
Rubin MR; Bilezikian JP
Curr Opin Rheumatol; 2002 Jul; 14(4):433-40. PubMed ID: 12118181
[TBL] [Abstract][Full Text] [Related]
4. [Anabolic therapy of osteoporosis].
Fernández-García D; Alonso G; Muñoz-Torres M
Med Clin (Barc); 2005 Sep; 125(9):341-5. PubMed ID: 16185635
[TBL] [Abstract][Full Text] [Related]
5. Anabolic agents: a new chapter in the management of osteoporosis.
Khan AW; Khan A
J Obstet Gynaecol Can; 2006 Feb; 28(2):136-41. PubMed ID: 16643716
[TBL] [Abstract][Full Text] [Related]
6. The cellular and clinical parameters of anabolic therapy for osteoporosis.
Rosen CJ
Crit Rev Eukaryot Gene Expr; 2003; 13(1):25-38. PubMed ID: 12839095
[TBL] [Abstract][Full Text] [Related]
7. Anabolic skeletal therapy for osteoporosis.
Girotra M; Rubin MR; Bilezikian JP
Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):745-54. PubMed ID: 17117299
[TBL] [Abstract][Full Text] [Related]
8. Treatment of osteoporosis: role of bone-forming agents.
Reginster JY; Halkin V; Henrotin Y; Gosset C
Osteoporos Int; 1999; 9 Suppl 2():S91-6. PubMed ID: 10525731
[No Abstract] [Full Text] [Related]
9. Past and future of anabolic agents.
Ringe JD
Ann Med Interne (Paris); 2000 Oct; 151(6):482-9. PubMed ID: 11104928
[No Abstract] [Full Text] [Related]
10. Anabolic agents for treating postmenopausal osteoporosis.
Meunier PJ
Joint Bone Spine; 2001 Dec; 68(6):576-81. PubMed ID: 11809001
[TBL] [Abstract][Full Text] [Related]
11. Anabolic effects of PTH and the 'anabolic window'.
Pazianas M
Trends Endocrinol Metab; 2015 Mar; 26(3):111-3. PubMed ID: 25662368
[TBL] [Abstract][Full Text] [Related]
12. New anabolic agents in the treatment of osteoporosis.
Hough S
S Afr Med J; 2003 Oct; 93(10):754-6. PubMed ID: 14652963
[No Abstract] [Full Text] [Related]
13. The potential of parathyroid hormone as a therapy for osteoporosis.
Rubin MR; Bilezikian JP
Int J Fertil Womens Med; 2002; 47(3):103-15. PubMed ID: 12081255
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone: an anabolic treatment for osteoporosis.
Morley P; Whitfield JF; Willick GE
Curr Pharm Des; 2001 May; 7(8):671-87. PubMed ID: 11375775
[TBL] [Abstract][Full Text] [Related]
15. Clinical review 123: Anabolic therapy for osteoporosis.
Rosen CJ; Bilezikian JP
J Clin Endocrinol Metab; 2001 Mar; 86(3):957-64. PubMed ID: 11238469
[TBL] [Abstract][Full Text] [Related]
16. Miscellaneous and experimental agents.
Reginster JY
Am J Med Sci; 1997 Jan; 313(1):33-40. PubMed ID: 9001164
[TBL] [Abstract][Full Text] [Related]
17. Full length parathyroid hormone, PTH(1-84), for the treatment of severe osteoporosis in postmenopausal women.
Adami S
Curr Med Res Opin; 2008 Nov; 24(11):3259-74. PubMed ID: 18940041
[TBL] [Abstract][Full Text] [Related]
18. The effects of parathyroid hormone peptides on the peripheral skeleton of postmenopausal women. A systematic review.
Metcalf LM; Aspray TJ; McCloskey EV
Bone; 2017 Jun; 99():39-46. PubMed ID: 28286298
[TBL] [Abstract][Full Text] [Related]
19. Optimal dosing and delivery of parathyroid hormone and its analogues for osteoporosis and hypoparathyroidism - translating the pharmacology.
Tay D; Cremers S; Bilezikian JP
Br J Clin Pharmacol; 2018 Feb; 84(2):252-267. PubMed ID: 29049872
[TBL] [Abstract][Full Text] [Related]
20. Anabolic agents and bone quality.
Sibai T; Morgan EF; Einhorn TA
Clin Orthop Relat Res; 2011 Aug; 469(8):2215-24. PubMed ID: 21132409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
